Asia Beat: Myanmar, Asia's next pharma frontier?

If anecdotal evidence is anything to go by, Myanmar (Burma) is fast developing as the next blip on Big Pharma's Asian radar, driven by the usual emerging market attraction of solid economic growth and particularly in this case by the prospect of political reforms viewed favourably by major potential trading partners.